Monoclonal Antibody Biosimilars

The first mAb biosimilars to be approved in Europe and elsewhere was the infliximab biosimilars (Inflectra and Remsima), which originator is Remicade. In October 2013, after the European Medicines Agency (EMA) gave a positive opinion for infliximab biosimilars, the European Commission granted a marketing authorization (MA) for these two biosimilars in the various therapeutic indications that are authorized for Remicade (i.e. indications in gastroenterology, rheumatology, and dermatology). As for previously approved biosimilars, the two aforementioned European institutions did not make a stand on the issues of substitution, and with good reason, as answering these questions does not fall within their areas of expertise and is the sole responsibility of EU Member States.

    Related Conference of Monoclonal Antibody Biosimilars

    January 06-07, 2025

    29th Annual Meeting on Pharmaceutical Biotechnology

    London, UK
    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    February 27-28, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    April 07-08, 2025

    4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems

    Vancouver, Canada
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    21st International Conference on Pharmaceutical Chemistry

    Rome, Italy
    May 05-06, 2025

    17th International Conference on Pharmaceutical Education and Practice

    Vancouver, Canada
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    May 19-20, 2025

    16th Annual Congress on Bioavailability and Bioequivalence

    Rome, Italy
    May 19-20, 2025

    7th International Conference and Exhibition on Pain Management

    Zurich, Switzerland
    June 02-03, 2025

    31st International Conference on Advanced Clinical Research and Clinical Trials

    Amsterdam, Netherlands
    June 10-11, 2025

    24th International Conference on Medicinal and Pharmaceutical Chemistry

    Vancouver, Canada
    June 10-11, 2025

    7th International Conference and Exhibition on Pharmaceutical Development and Technology

    Vancouver, Canada
    June 16-17, 2025

    18th International Conference and Exhibition on Pharmacovigilance & Drug Safety

    Frankfurt, Germany
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry

    Paris, France
    June 23-24, 2025

    27th International Congress on Pharmaceutical Biotechnology Research

    Paris, France
    June 23-24, 2025

    38th World Congress on Pharmacology

    Aix-en-Provence, France
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Paris, France
    August 21-22, 2025

    5th International Conference on Pharmaceutical Chemistry

    Dublin, Ireland
    September 08-09, 2025

    26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

    Frankfurt, Germany
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 16-17, 2025

    18th International Conference on Pharmaceutics and Drug Safety

    Berlin, Germany
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Paris, France
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Monoclonal Antibody Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in